The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Postmenopausal Hypertension: Mechanisms and Therapy
Abstract
ypertension in women is often undiagnosed or inade- quately treated, especially after menopause when cardiovascular risk increases.In premenopausal women, endogenous estrogens maintain vasodilation and thus contribute to blood pressure control.Aging and the loss of endogenous estrogen production after menopause are accompanied by increases in blood pressure, contributing to the high prevalence of hypertension in older women.Currently, Ϸ75% of postmenopausal women in the United States are hypertensive.The high prevalence of obesity, the lack of regular physical exercise, and dietary salt are important factors contributing to and aggravating postmenopausal hypertension.In view of the ongoing population aging throughout the world, diagnosis and treatment of hypertension in postmenopausal women are important to reduce the excess burden of associated cardiovascular disease and to improve outcomes of potentially fatal complications such as stroke and myocardial infarction.This article discusses current knowledge about the mechanisms and therapeutic issues related to postmenopausal hypertension. Hypertension: Important Determinant of Cardiovascular Risk in WomenMore than 25% of the female adult world population is hypertensive. 1Elevations in blood pressure in women are related to cardiovascular risk (Figure, panel A), 2,3 with the prevalence of hypertension being particularly high among women aged Ն60 years. 1 In the United States, Ϸ75% of postmenopausal women are hypertensive. 4Hypertension is often accompanied by other cardiovascular risk factors, eg, obesity, dyslipidemia, and diabetes mellitus. 5It is noteworthy that the prevalence of hypertension-related cardiovascular complications is greater in postmenopausal women than in age-matched men. 6Indeed, these complications represent the leading cause of death in women. 6linical studies have documented beneficial effects of antihypertensive therapy on cardiovascular outcome, 5 even in patients Ն80 years of age. 7Overall recognition, control, and treatment of hypertension in postmenopausal women are still poor in primary care, and hypertension is often not being treated aggressively enough. 4,8 -10Thus, further improve-ments of medical and public health measures, awareness of patients and physicians, and improved information policies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Research works printed but not linked: 74
- 10.1016/S0140-6736(05)70151-3 · DOI · Paper page
- 10.1056/NEJMoa003417 · DOI · Paper page
- 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
- 10.1161/hyp.36.5.780 · doi:10.1161/hyp.36.5.780
- 10.1161/hypertensionaha.107.107086 · DOI
- 10.1016/S0008-6363(01)00527-2 · DOI · Paper page
- 10.1161/01.hyp.0000223064.62762.0b · DOI · Paper page
- 10.1097/00004872-200211000-00002 · DOI
- 10.1161/01.hyp.8.11.1044 · DOI · Paper page
- 10.1016/j.maturitas.2004.01.010 · DOI
- 10.1161/hypertensionaha.107.105742 · DOI · Paper page
- Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989; 3: 427–433.
- 10.1016/S0378-5122(99)00089-4 · DOI
- 10.1016/j.amjhyper.2007.04.019 · DOI
- 10.1210/jc.2007-0425 · DOI · Paper page
- 10.1016/S0378-5122(03)00252-4 · DOI
- 10.1161/ATVBAHA.106.130260 · DOI
- 10.1161/01.hyp.0000151825.36598.36 · DOI · Paper page
- 10.1007/s11906-006-0080-1 · DOI · Paper page
- 10.1016/j.genm.2008.03.005 · doi:10.1016/j.genm.2008.03.005
- 10.1007/s100380070002 · DOI
- 10.1097/01.hjh.0000188728.66183.92 · DOI
- 10.1146/annurev.physiol.70.113006.100518 · DOI · Paper page
- 10.1161/hypertensionaha.107.089995 · DOI · Paper page
- 10.1016/j.genm.2008.03.004 · DOI
- 10.1016/j.amjhyper.2004.08.009 · DOI · Paper page
- 10.1093/ndt/13.6.1430 · DOI
- 10.1161/hyp.37.2.645 · doi:10.1161/hyp.37.2.645
- 10.1016/S0002-9440(10)63929-6 · DOI
- 10.1159/000092984 · DOI
- 10.3109/10641968309048813 · DOI
- 10.1161/hyp.27.3.481 · doi:10.1161/hyp.27.3.481
- 10.1016/0895-7061(95)00268-5 · DOI
- 10.1016/S0895-7061(97)00226-4 · DOI
- 10.1016/S0140-6736(97)05189-1 · DOI · Paper page
- 10.1161/01.hyp.0000245138.09687.8a · DOI
- 10.1161/01.hyp.0000218857.67880.75 · DOI
- 10.1097/00004872-200312000-00031 · doi:10.1097/00004872-200312000-00031
- 10.1097/01.ASN.0000128219.65330.EA · DOI · Paper page
- 10.1016/j.genm.2008.05.002 · doi:10.1016/j.genm.2008.05.002
- 10.1097/GME.0b013e31803c764d · DOI · Paper page
- 10.1124/jpet.103.058057 · DOI
- 10.1210/jc.2005-2339 · DOI
- 10.1158/1078-0432.CCR-04-1789 · DOI
- 10.7326/0003-4819-121-12-199412150-00005 · DOI · Paper page
- 10.1016/S0378-5122(99)00051-1 · doi:10.1016/s0378-5122(99)00051-1
- 10.1210/jcem.84.6.5724 · DOI · Paper page
- 10.1378/chest.127.5.1498 · DOI
- 10.1016/j.cardiores.2004.12.012 · DOI · Paper page
- 10.1016/j.atherosclerosis.2005.03.043 · DOI · Paper page
- 10.1056/NEJM200201033460114 · DOI
- Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC, for the WHISP (Women’s Hormone Intervention Secondary Prevention Study) Pilot Study Investigators. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. Eur Heart J. 2006; 27: 1046–1053.
- 10.1055/s-0037-1616085 · DOI
- 10.1016/j.amjhyper.2005.10.006 · DOI
- 10.1016/S0029-7844(97)84258-5 · DOI
- 10.1161/circ.103.24.2903 · doi:10.1161/circ.103.24.2903
- 10.1038/nm0397-324 · DOI · Paper page
- 10.1161/hypertensionaha.107.106575 · DOI
- 10.1161/circ.94.3.483 · doi:10.1161/circ.94.3.483
- 10.1021/ja01645a010 · DOI · Paper page
- 10.1161/hyp.29.4.976 · doi:10.1161/hyp.29.4.976
- 10.1093/eurheartj/ehm296 · DOI · Paper page
- Preston RA Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women. Climacteric. 2007; 10 (suppl 1): 32–41.
- 10.1016/j.amjcard.2004.07.153 · DOI
- 10.1097/00004872-199312000-00011 · DOI
- 10.1161/hypertensionaha.108.110478 · DOI
- 10.1080/gye.15.5.397.405 · DOI
- 10.1097/gme.0b013e318150d13e · DOI
- Meyer MR Haas E Prossnitz ER Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. In press.
- Prossnitz ER Barton M. Signaling physiological functions and clinical relevance of the G-protein-coupled estrogen receptor GPER. Prostaglandis Other Lipid Mediat. In press.
- Lindsey SH Cohen JA Brosnihan KB Gallagher PE Chappell MC. Chronic treatment with the GPR30 agonist G-1 decreases blood pressure in ovariectomized mREN2 Lewis rats. Endocrinology. In press.
- 10.1161/01.hyp.0000032940.33466.12 · DOI · Paper page
- 10.1161/hypertensionaha.107.099234 · DOI
- 10.1161/hypertensionaha.108.128033 · doi:10.1161/hypertensionaha.108.128033
Cited by
Gender differences in coronary heart disease
Maas, A. H. E. M., & Appelman, Y. E. A. (2010) · Netherlands Heart Journal · doi:10.1007/s12471-010-0841-y · Cited by 983
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925
“Cardiovascular system Endogenous 17β-estradiol is implicated in sex-specific differences observed in arterial hypertension and cardiovascular disease”
BackgroundSelf-citationGender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
(2016) · European Heart Journal · doi:10.1093/eurheartj/ehv598 · Cited by 739
Meyer, M. R., Clegg, D. J., Prossnitz, E. R., & Barton, M. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02237.x · Cited by 332
Self-citationEndothelin: 30 Years From Discovery to Therapy
Barton, M., & Yanagisawa, M. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12105 · Cited by 295
Self-citation
Metadata
- Authors
- Barton, M., & Meyer, M. R.
- Venue
- Hypertension
- Published
- 2009-07
- Volume
- 54
- Issue
- 1
- Pages
- 11-18
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2076013115
- Cited by
- 226
- References
- 16
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postmenopausal Hypertension: Mechanisms and Therapy. https://app.cochat.ai/papers/10.1161/hypertensionaha.108.120022
- The paper
- Barton, M., & Meyer, M. R. (2009). Postmenopausal Hypertension: Mechanisms and Therapy. Hypertension. https://doi.org/10.1161/hypertensionaha.108.120022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.